FDA Regulation and the Dynamic Nature of AI - Takeaways - MDSpire

Regulatory Frameworks for AI and Their Evolving Landscape

By
kffconnorg
September 15, 2026

Kaiser Family Foundation

Share

1

The FDA's 1976 framework for medical devices is being examined for its applicability to evolving AI technologies.
2

Dr. Brian Miller emphasizes that current manual medical systems may be less safe than perceived.
3

Miller warns against fear-driven regulation that could hinder the potential benefits of AI in healthcare.
4

The FDA has issued a discussion paper seeking stakeholder feedback on potential regulatory approaches for AI.
5

Chip Kahn hosts discussions on the intersection of health care, policy, and the impact of AI technologies.

Original Source(s)

Kaiser Family Foundation

FDA Regulation and the Dynamic Nature of AI

by kffconnorg
September 15, 2026

Related Content

Acr Open Rheumatology

Correction to “HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study”

September 15, 2026

Journal Of Medical Internet Research

Attitudes Toward Large Language Models in Health Care and Preferences for Their Adoption and Oversight Among Health Care Professionals: Cross-Sectional Survey

The Medicine Maker

AI-Designed Binder Improves CAR T Cell Activity in Mice

Researchers screened 1,758 de novo protein binders and identified design features that influence CAR T cell activation, specificity, and tumor control

September 15, 2026
3 min